e-learning
resources
Vienna 2012
Monday, 03.09.2012
New drug targets and pre-clinical models for respiratory diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Synbiotics reduce airway inflammation and improve airway function in a mouse model for COPD
G. Bezemer, M. Diks, P. Vos, J. Garssen, P. Henricks, A. Kranevels, G. Folkerts (Utrecht, Wageningen, Netherlands)
Source:
Annual Congress 2012 - New drug targets and pre-clinical models for respiratory diseases
Session:
New drug targets and pre-clinical models for respiratory diseases
Session type:
Oral Presentation
Number:
2806
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Bezemer, M. Diks, P. Vos, J. Garssen, P. Henricks, A. Kranevels, G. Folkerts (Utrecht, Wageningen, Netherlands). Synbiotics reduce airway inflammation and improve airway function in a mouse model for COPD. Eur Respir J 2012; 40: Suppl. 56, 2806
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Airway remedeling in a mouse model of chronic asthma: relation between the degree of airway remodeling and airway hyperresponsiveness
Source: Eur Respir J 2004; 24: Suppl. 48, 38s
Year: 2004
Effects of N-acetylcysteine on airway inflammation, airway hyperresponsiveness and abnormal lung function in chronic ozone-induced COPD model
Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD
Year: 2012
Airway hyperresponsiveness in asthma: lessons from in vitro model systems and animal models
Source: Eur Respir J 2008; 32: 487-502
Year: 2008
The influence of obesity on bronchial hyperresponsiveness, airway and systemic inflammation, lung function and quality of life in patients with asthma
Source: Annual Congress 2008 - Asthma: growing understanding of influential factors
Year: 2008
MMP-9 deficiency reduces airway inflammation and hyperresponsiveness in a mouse model of asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 20s
Year: 2001
The impact of obesity on airway and lung parenchyma remodelling in a murine model of chronic allergic asthma
Source: Annual Congress 2008 - Asthma: growing understanding of influential factors
Year: 2008
Development of a mouse model of airway inflammation and remodeling in experimental asthma
Source: Annual Congress 2007 - Mouse models of allergic airway inflammation
Year: 2007
Corticosteroids prevent airway remodeling in a mouse model of chronic asthma through TGF-β signaling
Source: Eur Respir J 2006; 28: Suppl. 50, 225s
Year: 2006
Obesity enhances allergen-induced airway inflammation in a murine model of asthma
Source: International Congress 2019 – Modelling and monitoring of airway diseases
Year: 2019
Basic mechanisms of development of airway structural changes in asthma
Source: Eur Respir J 2007; 29: 379-389
Year: 2007
Photobiomodulation and corticosteroid modulate pulmonary inflammation and airway reactivity in an experimental model of chronic asthma
Source: International Congress 2018 – Basic pharmacology
Year: 2018
Association between airway inflammation, disease control and lung function parameters in asthma
Source: Annual Congress 2010 - Cough, airway hyperresponsiveness and asthma control
Year: 2010
Airway inflammation in COPD: physiological outcome measures and induced sputum
Source: Eur Respir J 2003; 21: 19S-28S
Year: 2003
Airway epithelial inflammatory responses and clinical parameters in COPD
Source: Eur Respir J 2003; 22: 94-99
Year: 2003
Are we ready to monitor inflammation and remodelling in asthma?
Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not?
Year: 2005
Effect of aerobic training on the development of airway inflammation and remodeling and lung respiratory mechanics in an asthma model
Source: Annual Congress 2009 - Animal models of airways inflammation
Year: 2009
Continuous airway inflammation is related to the development of airway remodeling
Source: Annual Congress 2012 - Mechanisms and modulation of allergic inflammation in the lung
Year: 2012
Stem cell therapy attenuates airway and lung parenchyma remodeling in a murine model of chronic allergic asthma
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma
Year: 2008
Moderate aerobic conditioning decreases allergic airway inflammation and airway remodeling in chronically sensitized mice
Source: Annual Congress 2006 - Immunology of the airways
Year: 2006
Dynamic hyperinflation contributes to systemic and airway inflammation in patients with COPD
Source: International Congress 2019 – Physiologic assessment of airway diseases
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept